CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-55 Cr | ₹-109 Cr | ₹-146 Cr | ₹129 Cr | ₹224 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CIPLA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-55 Cr |
Mar2023 | ₹-109 Cr |
Mar2022 | ₹-146 Cr |
Mar2021 | ₹129 Cr |
Mar2020 | ₹224 Cr |
How is Net Cash Inflow / Outflow of CIPLA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-55 Cr | Negative | |
Mar2023 | ₹-109 Cr | Negative | |
Mar2022 | ₹-146 Cr | Negative | |
Mar2021 | ₹129 Cr | -42.54 | |
Mar2020 | ₹224 Cr | - |
Compare Net Cash Inflow / Outflow of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹118,038.8 Cr | 0.2% | 0.6% | -3.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,012.0 Cr | 4.6% | -0.9% | 5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,188.0 Cr | 0.5% | -5.5% | 57.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,512.0 Cr | -0.4% | -1.5% | 14.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,445.1 Cr | -2.2% | -8.6% | -13.4% | Stock Analytics | |
MANKIND PHARMA | ₹90,812.7 Cr | -4.9% | -10.2% | 0.3% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 0.2% |
0.6% |
-3.3% |
SENSEX | -0.7% |
-4.5% |
-0.4% |
You may also like the below Video Courses